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The crystal structure is shown in the figure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters.
Source of materials
The title compound was synthesized by Aldol condensation between two molecules of 2-(trifluoromethyl)benzaldehyde and cyclopentanone, which was synthesized according our earlier published method [1, 2] . In detail: 5.0 mmol cyclopentanone was added to a solution of 10 mmol 2-(trifluoromethyl)benzaldehyde in MeOH (10 mL). The solution was stirred at room temperature for 30 min, followed SHELX [13] by dropwise addition of NaOCH 3 /CH 3 OH (1.0 mL, 5.0 mmol). The mixture was stirred at room temperature and monitored with TLC. When the reaction was finished, the residue was poured into saturated NH 4 Cl solution and filtered. The precipitate was washed with water and cold ethanol, and dried in vacuum. The solid was further purified by silica gel chromatography (CH 2 Cl 2 /CH 3 OH). All chemicals used for the synthesis were commercially available and were used without further purification. The yellow crystals of the title compound were obtained by slow evaporation of a CH 3 OH solution at room temperature.
Experimental details
Position of the H atoms were calculated based on geometric criteria (C-H = 0.97 and 0.93 for methyl and aromatic atoms, respectively) and placed in their calculated position and refined, using a riding model with U iso (H) = 1.5 U eq (C) for methyl and U iso (H) = 1.2 U eq (C) for all others.
Discussion
Curcumin has been demonstrated to possess a wide range of pharmaceutical activities, such as anti-tumor [3, 4] , antiinflammation [5] , anti-oxidation [6] , anti-bacterial [7] , and cardiovascular protection [8, 9] . However, its high metabolic instability and low bioavailability have dramatically limited its practical application [10] . Recently, our research group has synthesized a series of mono-carbonyl analogs of curcumin (MACs) by deleting β-diketone moiety [11, 12] The symmetrical unit of this complex is constructed by two 2-(trifluoromethyl)benzylidene groups and a cyclopentanone linker. The C-C bond lengths of the cyclopentanone moiety are with 1.477(4) to 1.543(4) Å quite normal. The C8-C9 and C12-C14 bond lengths of 1.326(4) and 1.340(4) Å conform to a double bond. The C6-C8 and C14-C15 bond lengths of 1.477(5) and 1.465(5) Å are between double and single bonds. The shortening of the C-C bonds showing the partial double-bond character of the C-C bonds, which are influenced by adjacent double bonds.
